NCT06751784View on ClinicalTrials.gov

Cross-over Study on the Influence of Fampridine on Working Memory in Mild Depression

PHASE2RecruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 22, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Working MemoryMild Depression
Interventions
DRUG

Fampridine SR

Active study medication consists of 15 tablets of fampridine SR 10 mg formulated for oral administration taken in the morning and evening 12 h apart without food. Tablets must be administered whole.

OTHER

Placebo

no active substance

Trial Locations (1)

4055

RECRUITING

University of Basel, Reserach Cluster Molecular and Cognitive Neurosciences, Basel

All Listed Sponsors
collaborator

Clinical Trial Unit, University Hospital Basel, Switzerland

OTHER

lead

University of Basel

OTHER